-
Product Insights
NewPancreatic Diseases – Drugs In Development, 2024
Empower your strategies with our Pancreatic Diseases – Drugs In Development, 2024 report and make more profitable business decisions. Pancreatic diseases encompass a range of conditions that affect the pancreas, a vital organ located behind the stomach. The pancreas plays a crucial role in digestion and hormone regulation by producing enzymes for digestion and hormones like insulin and glucagon that regulate blood sugar levels. The Pancreatic Diseases drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Product Insights
NewColitis – Drugs In Development, 2024
Empower your strategies with our Colitis – Drugs In Development, 2024 report and make more profitable business decisions. Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections with a virus or parasite or bacterial food poisoning; inflammatory disorders, namelsy ulcerative colitis and Crohn's disease; lack of blood flow (ischemic colitis); or past radiation exposure to the large bowel. Symptoms can include abdominal pain, bloating, bloody stools, chills, dehydration, diarrhea, and fever. Treatment includes...
-
Product Insights
NewGastroparesis – Drugs In Development, 2024
Empower your strategies with our Gastroparesis – Drugs In Development, 2024 report and make more profitable business decisions. Gastroparesis, also called delayed gastric emptying, is a disorder that slows or stops the movement of food from stomach to small intestine, even though there is no blockage in the stomach or intestines. The symptoms of gastroparesis may include feeling full shortly after starting a meal, feeling full long after eating a meal, nausea, and vomiting. Diabetes is the most common known cause...
-
Product Insights
NewProctitis – Drugs In Development, 2024
Empower your strategies with our Proctitis – Drugs In Development, 2024 report and make more profitable business decisions. Proctitis is an inflammation in the lining of rectum. It can be chronic or acute. Causes of proctitis include IBD, sexually transmitted and gastrointestinal infections, radiation therapy, antibiotics, and NSAIDs. Some of the symptoms include anorectal pain; blood, mucus, or pus in the feces; swelling in the rectum; tenesmus (continuous feeling of bowel movement); dyschezia (painful bowel movements); and diarrhea or constipation. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Niclosamide in Proctitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Niclosamide in Proctitis Drug Details: Niclosamide is under development for the treatment of ulcerative colitis,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Epcoritamab in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Epcoritamab in Follicular Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Epcoritamab in Follicular Lymphoma Drug Details: Epcoritamab-Bysp (Epkinly) is a monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – WP-1303 in Multiple Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - WP-1303 in Multiple Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. WP-1303 in Multiple Sclerosis Drug Details: WP-1303 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Niclosamide in Ulcerative Colitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Niclosamide in Ulcerative Colitis Drug Details:Niclosamide is under development for the treatment of ulcerative colitis, proctitis...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belatacept in Lung Transplant Rejection
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Belatacept in Lung Transplant Rejection Drug Details:Belatacept (Nulojix) is a soluble fusion protein consisting of a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adrulipase alfa in Exocrine Pancreatic Insufficiency
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adrulipase alfa in Exocrine Pancreatic Insufficiency report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Adrulipase alfa in Exocrine Pancreatic InsufficiencyDrug Details:Adrulipase alfa is under development...